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Interoception refers to the process by which the nervous system senses, interprets, and integrates signals
originating from within the body, providing a moment-by-moment mapping of the body’s internal landscape
across conscious and unconscious levels. Interoceptive signaling has been considered a component process of
reﬂexes, urges, feelings, drives, adaptive responses, and cognitive and emotional experiences, highlighting its
contributions to the maintenance of homeostatic functioning, body regulation, and survival. Dysfunction of
interoception is increasingly recognized as an important component of different mental health conditions,
including anxiety disorders, mood disorders, eating disorders, addictive disorders, and somatic symptom dis-
orders. However, a number of conceptual and methodological challenges have made it difﬁcult for interoceptive
constructs to be broadly applied in mental health research and treatment settings. In November 2016, the
Laureate Institute for Brain Research organized the ﬁrst Interoception Summit, a gathering of interoception ex-
perts from around the world, with the goal of accelerating progress in understanding the role of interoception in
mental health. The discussions at the meeting were organized around four themes: interoceptive assessment,
interoceptive integration, interoceptive psychopathology, and the generation of a roadmap that could serve as a
guide for future endeavors. This review article presents an overview of the emerging consensus generated by the
meeting.
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https://doi.org/10.1016/j.bpsc.2017.12.0041 Visceroception has classically referred to the perception of bodily
signals arising speciﬁcally from visceral organs, such as the
heart, lungs, stomach, intestines, and bladder, along with other
internal organs in the trunk of the body (19). It did not include
organs such as the skin and skeletal muscle, in contrast to
contemporary deﬁnitions of interoception that typically en-
compasses signals from both the viscera and all other tissues
that relay a signal to the central nervous system about the
current state of the body, including the skin and skeletal/
smooth muscle ﬁbers, via lamina I spinothalamic afferents
(41,138,139).Interoception refers collectively to the processing of internal
bodily stimuli by the nervous system. Parcellation of the
nervous system’s processing of sensory signals into inter-
oception, proprioception, and exteroception began more
than 100 years ago (1), although it was predated by interest
in linking body–brain interactions with conscious experience
(2,3). Scientiﬁc interest in interoception has ﬂuctuated
(Figure 1A). During the 1980s, biological psychiatry was
inundated with observations of interoceptive disturbances in
panic disorder (4–7), although the trend receded after it
became clear that the etiological mechanism was broader
than a single molecular receptor target (8). Recent years
have witnessed a surge of interest on the topic of inter-
oception due in part to ﬁndings highlighting its integral role
in emotional experience, self-regulation, decision making,
and consciousness. Importantly, interoception is not limited
to conscious perception or even unique to the human spe-
cies. From this perspective, interdisciplinary efforts to un-
derstand different features of interoception have been
essential for advancing progress in cognitive and clinical
neuroscience (Figure 1B).ª 2017 Society of Biological Psychiatry. Pu
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Body Systems of Interoception
Interoceptive processing occurs across all major biological
systems involved in maintaining bodily homeostasis, including
the cardiovascular (9,10), pulmonary (11), gastrointestinal
(12,13), genitourinary (14), nociceptive (15), chemosensory
(16), osmotic (17), thermoregulatory (18), visceral1 (19), immune
(20,21), and autonomic systems (22,23) (Table 1). There hasblished by Elsevier Inc. This is an open access article under the
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. (A) Number of English language pub-
lications per year on interoception from PubMed,
PsycINFO, and Institute for Science Information
Web of Knowledge. The timeline starts in 1905, one
year before the publication of Charles Sherrington’s
book, The Integrative Action of the Nervous Sys-
tem, which ﬁrst deﬁned the concept of inter-
oception. Key historical events relevant to
interoception science are superimposed. (B) Pub-
lications per year on interoception vs. those inves-
tigating features of interoception that do not
speciﬁcally refer to the term. These latter publica-
tions are more numerous and arise mainly from
basic neuroscience, physiology, and subspecialty
disciplines within the biomedical ﬁeld. Note the use
of a logarithmic scale in the second panel.
[Figure reproduced and modiﬁed with permission
from Khalsa and Lapidus (33).]
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bodily systems; thus, it is not surprising that most in-
vestigations of the topic have been siloed within distinct
research areas or scientiﬁc disciplines [see (24,25) for note-
worthy exceptions].
Features of Interoception
Interoception is not a simple process but rather has several
facets (26). The act of sensing, interpreting, and integrating
information about the state of inner body systems can be
related to different elements such as interoceptive attention,
detection, discrimination, accuracy, insight, sensibility, and
self-report (Table 2). However, most interoceptive processes
occur outside the realm of conscious awareness. Consciously
experienced elements are measured clinically via subjective
report, and there are few observable interoceptive signs (e.g.,
heart rate, respiration rate, pupillary dilation, ﬂushing, perspi-
ration, piloerection, nociceptive reﬂexes) (Table 3). Experi-
mental approaches can quantify different body systems and
features of interoceptive processing. Nevertheless, these
measures are only partially overlapping and likely reﬂect
somewhat distinct neural processes (27). Access to the full
range of interoceptive signals often involves invasive ap-
proaches, which tend to elicit physiological perturbations and
index more objectively measurable features (28). However,2 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging - 2many insights have been gained by the application of nonin-
vasive approaches within neuroscience and psychological
assessment contexts (29) (see “Eavesdropping on Brain–Body
Communication” section below).
Importance of an Interoceptive Taxonomy
There is no generally agreed-on taxonomy for interoception
science. Variable deﬁnitions have made it difﬁcult to identify
the features under investigation, let alone evaluate the quality
of the ﬁndings. Based on the number of physiological systems
involved, it could be questioned whether the terms “inter-
oception” and “interoceptive awareness” are too broad.
Interoceptive awareness is an umbrella term that was ﬁrst used
to describe a self-report subscale (30), but it has subsequently
been used to encompass any (or all) of the different inter-
oception features accessible to conscious self-report. Re-
searchers from different ﬁelds developed deﬁnitions that only
partially overlapped, reﬂecting the need for operationalization
in neuroscience (31,32) and clinical practice (33,34). Here we
develop a more coherent nomenclature for its various com-
ponents (Table 2), mirroring developments in other ﬁelds,
especially pain (35). One key aspect is the importance of dis-
tinguishing sensation (i.e., the raw signals conveyed by bodily
sensors) from perception (36,37). We return to this theme
below.018; -:-–- www.sobp.org/BPCNNI
Table 1. Physiological Processes Often Ascribed to
Interoception
Nonpainful
Cardiovascular, respiratory, gastrointestinal (esophageal, gastric,
intestinal, colorectal), bladder, hunger, thirst, blood/serum
(pH, osmolality, glucose), temperature, vasomotor ﬂush,
air hunger, muscle tension, shudder, itch, tickle, genital sensation,
sensual touch, fatigue
Painful
Visceral: kidney stone, pleuritic, angina, pericardial, bowel ischemia,
pelvic, sickle crisis
Somatic: abscess/boil, bruising, myalgia, inﬂammation (systemic/
laceration), headache
Skeletal: fractured/bruised bone, stress fracture, inﬂammatory/
mechanical joint pain
Several key distinctions are that interoceptive sensing 1) may be
painful or nonpainful, 2) occurs across the spectra of high/low
arousal and negative/positive valence, 3) usually occurs outside of
conscious awareness (with the exception of pain sensations), and 4)
is often (but not always) consciously experienced during instances of
homeostatic perturbation.
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While interoception research to date has typically focused on
single organ systems, an expanded approach that assesses
multiple interoceptive organ systems and/or elements is
needed. Examples include targeting numerous interoceptive
features simultaneously and employing different tasks that
converge on the same feature (e.g., combining top-down
assessments of interoceptive attention with bottom-up
perturbation approaches in the same individual) (Figure 2A).
Sensing Perturbations
The inner and outer worlds of the body constantly ﬂuctuate.
The nervous system monitors these environmental changes
and responds adaptively in order to maintain a homeostatic
balance and promote survival. Because psychiatric disorders
often promote or reﬂect the development of chronic ho-
meostatic and allostatic disturbances (38), there is a need for
methods capable of eliciting homeostatic perturbations inTable 2. Features of Interoceptive Awareness
Feature Deﬁnition
Attention Observing internal body sensations
Detection Presence or absence of conscious report
Magnitude Perceived intensity
Discrimination Localize sensation to a speciﬁc channel or
organ system and differentiate it
from other sensations
Accuracy (Sensitivity) Correct and precise monitoring
Insight Metacognitive evaluation of experience/
performance (e.g., conﬁdence–accuracy
correspondence)
Sensibility Self-perceived tendency to focus on
interoceptive stimuli (trait measure)
Self-report Scales Psychometric assessment via questionnaire
(state/trait measure)
For some examples of paradigms assessing each feature, see
Supplemental Table S1.
Biological Psychiatry: Cognitive Neurosciencontrolled settings, especially those assessing subjective and
behavioral responses to valence and arousal deviations.
However, interoception is not simply about afferent pro-
cessing. The brain’s constant monitoring of the body occurs
in service of optimizing homeostatic regulation. This efferent
limb is understudied (39), and paradigms that can effectively
measure visceromotor outputs will be critical to establish
sensitive assays of dysfunctional interoception and homeo-
static regulation (e.g., detection of visceromotor-efferent
neural signals controlling baroreﬂex sensitivity during modu-
lation of visceral-afferent input by sympathetic drugs). The
reliability and validity of methods should be rigorously
established.INTEGRATION
Interoception and Domain Speciﬁcity Within the
Brain
There are fundamentally differing ways to interpret the evolu-
tion of brain and body signaling in humans. The processing of
interoceptive input could be domain speciﬁc, with modular
processing occurring in specialized, encapsulated neural cir-
cuits [e.g., cardiac, respiratory, urinary, genital, chemical,
hormonal; see (40) for a review of domain speciﬁcity] or func-
tionally coupled (e.g., cardiorespiratory, genitourinary, che-
mohormonal) and integrated within a single neural circuit.
Understanding the adaptive origins and functions of intero-
ceptive domain speciﬁcity (if present) could tell us how the
implementation and deployment of interoceptive signals by the
nervous system contributes to disordered mental health.
Because interoceptive signaling involves afferent and efferent
inputs across multiple hierarchies within the autonomic and
central nervous systems, identifying where and how informa-
tion processing dysfunctions negatively affect mental health
represents a challenging problem.
Neural Pathways of Interoception
Several pathways have been implicated in the neural pro-
cessing of interoceptive signals, beginning with a rich
interface between autonomic afferents and the central
nervous system. Relay pathways involve primarily spinal,
vagal, and glossopharyngeal afferents, with multiple levels
of processing and integration in autonomic ganglia and
spinal cord (10,19,22,41). Several brainstem (nucleus of the
solitary tract, parabrachial nucleus, and periaqueductal
gray), subcortical (thalamus, hypothalamus, hippocampus,
and amygdala), and cortical regions (insula and somato-
sensory cortices) represent key afferent processing regions
(22,42,43). A complementary set of regions involved in
visceromotor actions represents key efferent processing
regions, including the anterior insula, anterior cingulate,
subgenual cingulate, orbitofrontal, ventromedial prefrontal,
supplementary motor, and premotor areas (44–46). It is
noteworthy that these neural regions coincide closely with
other sensory processing systems, especially the nocicep-
tive and affective systems. The degree to which these
represent distinct or overlapping systems is currently
unclear.ce and Neuroimaging - 2018; -:-–- www.sobp.org/BPCNNI 3
Table 3. Diagnostic Symptoms and Clinical Signs Indicating Interoceptive Dysfunction in Some Psychiatric Disorders
Psychiatric Disorder Symptoms Signs Sample Studies
Panic Disorder Palpitations, chest pain, dyspnea, choking,
nausea, dizziness, ﬂushing, depersonalization/
derealization
Elevated heart rate and/or blood pressure,
exaggerated escape, startle, and ﬂinching
(5,140,141)
Depression Increased or decreased appetite, fatigue, lethargy Weight gain, weight loss, psychomotor slowing (142,143)
Eating Disorders Hunger insensitivity, food anxiety, gastrointestinal
complaints
Severe food restriction, severe weight loss,
binging, purging, compulsive exercise
(72,98)
Somatic Symptom
Disorders
Multiple current physical and nociceptive
symptoms
Medical observations do not correspond with
symptom report
(144,145)
Substance Use Disorders Physical symptoms associated with craving,
intoxication, and/or withdrawal (drug speciﬁc)
Elevated/decreased: heart rate, respiratory rate,
and/or blood pressure, pupil dilation/
constriction, others (drug speciﬁc)
(101,146,147)
Posttraumatic Stress
Disorder
Autonomic hypervigilance, depersonalization/
derealization
Exaggerated startle, ﬂinching, and/or escape
responses, elevated heart rate and/or blood
pressure
(148)
Generalized Anxiety
Disorder
Muscle tension, headaches, fatigue,
gastrointestinal complaints, pain
Trembling, twitching, shaking, sweating, nausea,
exaggerated startle
(149,150)
Depersonalization/
Derealization Disorder
Detachment from one’s body, head fullness,
tingling, lightheadedness
Physiological hyporeactivity to emotional stimuli (151,152)
Autism Spectrum
Disorders
Skin hypersensitivity Selective clothing preferences (107,153,154)
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A particular challenge when examining interoception is the fact
that afferent sensory signals are integrated on several levels
(peripherally, within the spinal cord, and supraspinally) to form
sets of interoceptive maps across different body systems. The
brain appears to integrate information representing particular
states of multiple systems simultaneously (cardiac, respiratory,
chemical, hormonal, nociceptive, etc.) (41), and it is imperative
to be able to model and comparatively evaluate such map-
pings (Figure 2B). This poses many challenges. One approach
might be to apply measures that assess multiple organ sys-
tems or interoceptive features simultaneously [see (42,47,48)]
or to record activity across the brain, spinal cord, and peripheral
organs (49). However, it is also possible that multisystem as-
sessments may reduce speciﬁcity for certain disorders and
therefore may be unnecessary. For example, some patients
with panic disorder may experience dyspnea but not palpita-
tions. Localizing and then targeting the dysfunctional intero-
ceptive domain would become more useful than broad
multisystem interventions.Timing and Rhythm in Interoceptive Circuits
The physiological timescales and amplitudes of interoceptive
signaling vary dramatically (e.g., heart rate [0.5–3.3 Hz], res-
piratory rate [0.08–1 Hz], gastric contractility [0.05–0.1 Hz],
urinary frequency [0.000045–0.00012 Hz]), with even slower
changes in humoral mediators (50) (Figure 2C, D). They also
vary across individuals, and over the life span (e.g., increased
heart rates in infants/children). Despite the variance, the brain
tracks such changes in similar subregions, including the
insula, somatosensory cortices, cingulate, amygdala, thal-
amus, and brainstem (42,43,51–53). Temporal synchrony or
dyssynchrony between these systems may affect interocep-
tive experiences, affect, and behavior, although the exact
mechanisms require further study (54). Repetitive events are4 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging - 2another important element for learning, and while there are
numerous classic studies on visceral learning at the periph-
eral organ system level (55,56), we know little about the
central mapping of learned visceral memories, especially in
psychiatric disorders (57).
How Can Animal Research Improve the
Understanding of Human Interoceptive Processing?
Although the inability to measure the subjective state of an-
imals results in indirect inferences, well-established tasks
exist [e.g., conditioned interoceptive place preference (58)
and odor aversion (59)]. The principal utility of animal
models is the hypothesis testing of mechanistic processes at
the biological level independent of appraisal and cognition.
These include examining effects of peripheral or central ner-
vous system lesions on physiology/behavior, or mapping of
peripheral/central interactions via stimulation of selective
neurons/circuits using optogenetic methods (60,61), and
targeted gene expression manipulation to test genetic hy-
potheses (62). Animal models are advantageous in that they
allow for identiﬁcation of neural mechanisms that may be
distinct from higher cognitive processes (e.g., nonmammalian
[reptiles/birds] vs. mammalian [mice/rats/monkeys/apes/
chimpanzees], invertebrate [octopus] vs. vertebrate [ﬁsh/
monkeys]). The study of interoception in nonhuman primates
offers intriguing opportunities. Investigations in this area have
been centered primarily on neural encoding of baroreceptor
afferent stimulation (9) and neuroanatomical circuit tracing
(63). Fewer studies have examined relationships between
mechanistic manipulation of interoceptive experiences and
neural representation in these animals [see (64,65) for
exceptions].
Eavesdropping on Brain–Body Communications
Interoception is manifested by the conversation between the
body and brain via multiple afferent and efferent feedback018; -:-–- www.sobp.org/BPCNNI
Figure 2. (A) Cardiac interoceptive processing measures and feature loading. This illustrates how the most commonly used heartbeat perception tasks
differentially measure interoceptive features. [Figure reproduced and modiﬁed with permission from Khalsa and Lapidus (33).] (B) Multisystem interoceptive
processing measures and feature loadings: Example of hypothetical approaches to measuring interoceptive processing across multiple systems. Approaches
that perturb the state of the body are recommended, as are convergent approaches such as combined assessments of interoceptive attention and pertur-
bation. (C) Central neural integration of interoceptive rhythms. Interoceptive rhythms vary considerably across the different systems of the body. They exhibit
complex characteristics and are hierarchically integrated within discrete regions of the central nervous system. [Figure modiﬁed, with permission, from
Petzschner et al. (37).] (D) Interoceptive rhythms vary in both amplitude and frequency. The top trace illustrates a hypothetical example of an amplitude
modulation signal superimposed on a static frequency. The middle trace illustrates a hypothetical frequency modulation signal superimposed on a static
amplitude. The bottom trace illustrates a hypothetical signal change involving both amplitude and frequency modulations that are temporally correlated. GI,
gastrointestinal; GU, genitourinary.
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approaches. Peripheral perturbations are often used to stim-
ulate the afferent bottom-up transfer of information, usually of
mechanical (28,47,52,53), chemical (67–69), or hormonal (70)
origin (Supplemental Table S1). Central perturbations to
probe efferent top-down processes have most typically
involved selective regulation of attentional focus (29,71) and,
less commonly, expectancy manipulations such as placebo/
sham delivery (72). Functional magnetic resonance imaging
(73), positron emission tomography (74), and electroencepha-
lography (75,76) have provided the primary means of assess-
ing neural circuitry. However, a host of novel tools are capable
of inhibiting, stimulating, or modulating the activity of intero-
ceptive brain networks. Noninvasive methods include the
application of transcranial magnetic stimulation (77), trans-
cranial direct and alternating current stimulation (78), low-Biological Psychiatry: Cognitive Neuroscienintensity focused ultrasound (79), temporally interfering elec-
tric ﬁelds (80), transcutaneous vagus nerve stimulation (81),
presentation of information during different phases of visceral
rhythms (e.g., cardiac systole vs. diastole) (82), and assess-
ment of corticocardiac signaling (83). An important point is that
many of the critical brain structures are difﬁcult to modulate
noninvasively because they are located deep within the brain
or near the midline. Invasive measures do not share this limi-
tation, and while their implementation is driven by clinical
concerns, they can provide important insights. These include
implanted vagus nerve stimulation (84), direct brain stimulation
(85), and intracranial electrode recordings (86,87). Beyond
these perturbation tools, the use of experimental methods to
modulate expectancies, such as placebo and sham in-
terventions, is key. These methods will help to determine how
sensitive psychiatric and other clinical patients’ afferent/ce and Neuroimaging - 2018; -:-–- www.sobp.org/BPCNNI 5
Figure 3. (A) Example of one possible form of a general inference–control loop illustrated within a hierarchical Bayesian model. (B) Highly schematic
example of illustrating that both interoceptive information and exteroceptive information are concurrently integrated to inform perceptual representations and
action selection with respect to internally directed (e.g., visceromotor, autonomic) and externally directed (e.g., skeletomotor) actions. (C) General nodes that
comprise a peripheral and central neural circuit for hierarchically integrating afferent interoceptive information into homeostatic reﬂexes, sensory and meta-
cognitive representations, and allostatic regulators (predictions). ACC, anterior cingulate cortex; AIC, anterior insular cortex; MC, metacognitive layer; MIC,
midinsular cortex; OFC, orbitofrontal cortex; PE, prediction error; PIC, posterior insular cortex; SGC, subgenual cortex. [Panels (A) and (B) reproduced, with
permission, from Petzschner et al. (37). Panel (C) adapted, with permission, from Stephan et al. (36).]
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of environmental context with body–brain signals (illustrated in
the next section). Finally, neurofeedback (e.g., functional
magnetic resonance imaging, electroencephalogram) repre-
sents an exciting opportunity to participate in the brain–body
conversation by simultaneously measuring and modulating
brain regions during treatment [for a noninteroceptive example,
see (88)]. Equipped with these tools, the future looks prom-
ising, but to advance progress they need to be paired with
better models of brain function.
Computational Theories of Interoception
Identifying the state of the body represents a problem that
cannot be solved by pure sensing because afferent signals
from body sensors (interosensations) are not only noisy but
often ambiguous (89). Recent computational theories suggest
that interoception deploys Bayesian inference to address this
challenge (36,37,44,45,90,91) (Figures 3 and 4). Speciﬁcally,
the brain is assumed to construct a so-called generative model
of interosensations that combines a predictive mapping (from
hidden bodily states to interosensations) with prior information
(beliefs or expectations about bodily states represented as
probability distributions). This view is supported by ﬁndings
that interoceptive perception is strongly shaped by expecta-
tions (41,72,92,93) and by theoretical arguments that suggest
Bayesian inference as a unifying principle for interoception and
exteroception (37,91).
Another argument supporting a Bayesian view on inter-
oception is its relation to what constitutes arguably the brain’s
most fundamental task: the regulation (or control) of bodily6 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging - 2states. Put simply, if the brain were unable to resolve the
ambiguity of interosensations, it would face difﬁculties in
choosing appropriate actions to protect homeostasis. In
information-theoretic terms, the challenge of keeping bodily
states within narrow homeostatic ranges corresponds to
choosing actions that minimize the long-term average Shan-
non surprise (entropy) of interosensations (36,91). Solving this
control problem requires knowledge or estimations of current
and/or future bodily states and hence inference and
predictions/forecasts—two natural domains of generative
models.
Eliciting surprise-minimizing (homeostasis-restoring) ac-
tions changes the bodily state and thus interosensations. This
means that inference and control of bodily states form a closed
loop. Inference–control loops that minimize interoceptive sur-
prise can be cast as hierarchical Bayesian models (HBMs).
Anatomically, HBMs are plausible candidates given that
interoceptive circuitry is structured hierarchically (45,94). Un-
der general assumptions, HBMs employ a small set of
computational quantities—predictions, prediction errors, and
precisions (37,95). These quantities can support surprise
minimization in two ways: by adjusting beliefs (probability
distributions) throughout the hierarchy [predictive coding (95)]
or engaging actions that fulﬁll beliefs about bodily states
[active inference (96)].
HBMs support both homeostatic (reactive) and allostatic
(prospective) control. Reconsidering classical homeostatic
set points as beliefs (i.e., probabilistic representations of ex-
pected/desired bodily states) enables reactive regulation at the
bottom of the hierarchy (36,91); here, prediction errors elicit018; -:-–- www.sobp.org/BPCNNI
Figure 4. (A) Active inference implementation according to the Embodied Predictive Interoception Coding model. Agranular visceromotor cortices, including
the cingulate cortex, posterior ventral medial prefrontal cortex, posterior orbitofrontal cortex, and ventral anterior insula, estimate the balance among auto-
nomic, metabolic, and immunological resources available to the body and its predicted requirements. These agranular visceromotor cortices issue allostatic
predictions to hypothalamus, brainstem, and spinal cord nuclei to maintain a homeostatic internal milieu and simultaneously to the primary interoceptive
sensory cortex in the mid and posterior insula. The interoceptive sensory cortex in the granular mid and posterior insula sends reciprocal prediction error
signals back to the agranular visceromotor regions to modify the predictions. Under usual circumstances, these agranular regions are relatively insensitive to
such feedback, which explains why interoceptive predictions are fairly stable in the face of body ﬂuctuations. One hypothesis of the role of interoception in
mental illness is that interoceptive input (i.e., posteriors) becomes increasingly decoupled from interoceptive predictions issued by the agranular visceromotor
cortex (priors), leading to increased interoceptive prediction error signals. This decoupling may present in the brain as “noisy afferent interoceptive inputs” (97).
(B) Proposed intracortical architecture and intercortical connectivity for interoceptive predictive coding. The granular cortex contains six cell layers including
granule cells, which are excitatory neurons that amplify and distribute thalamocortical inputs throughout the column. The granular cortex is structurally similar
to the neocortex and therefore more recently evolved than the agranular and dysgranular cortices. Within the insula, the granular cortex is present in the mid
and posterior sectors. AC, anterior cingulate; PL, prelimbic cortex. [Figures reproduced, with permission, from Barrett and Simmons (45).]
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prise. Allostatic regulation at longer time scales is achieved
through modulation of homeostatic beliefs by inferred or fore-
cast states signaled from higher hierarchical levels (36).
Importantly, belief precision determines the force/pace of
corrective actions—that is, the tighter the expected range of
bodily state, the more vigorous the elicited regulatory action.
This offers a novel explanation for psychosomatic phenomena
and placebo effects (37).
In summary, a hierarchical Bayesian perspective uniﬁes
interoception and homeostatic/allostatic control under the
same computational principles. This provides a conceptual
foundation for computational psychosomatics and supports a
taxonomy of disease processes (37). One caveat is that the
empirical evidence for hierarchical Bayesian principles of
interoception and homeostatic/allostatic control is indirect so
far. Studies designed to probe hierarchical Bayesian pro-
cesses under experimentally controlled homeostatic pertur-
bations will be crucial for ﬁnessing (or refuting) current
computational concepts of interoception.
PSYCHOPATHOLOGY
Interoceptive Psychopathology
Several conceptual and heuristic models have linked dys-
functions of interoception to mental health conditions. Spe-
ciﬁcally, mood and anxiety disorders have been linked to
failures to appropriately anticipate changes in interoceptive
states (97). Eating disorders show behavioral and neuralBiological Psychiatry: Cognitive Neuroscienabnormalities in interoceptive processing, particularly in the
context of caloric anticipation (72,98–100), although it remains
unclear whether this is due to altered afferent signaling, altered
central sensory processing, abnormal temperament, and/or
metacognition. Drug addiction, another condition marked by
interoceptive disturbances, has an overlapping neural circuitry
and abnormal responses to interoceptive cues (101–104).
Interoceptive dysfunction also likely plays a role in conditions
such as posttraumatic stress disorder and somatic symptom
disorders (33). Other disorders also have interoceptive symp-
tom overlap; however, the speciﬁc feature involved may differ
according to the disorder or affected individual [e.g., chronic
pain (105,106), Tourette’s syndrome and other tic disorders,
borderline personality disorder, obsessive-compulsive disor-
der, autism spectrum disorder (107), functional developmental
disorders (108)]. Table 3 lists diagnostic symptoms and clinical
signs indicative of interoceptive dysfunction in several psychi-
atric disorders. Conditions that have a psychiatric component
include ﬁbromyalgia, chronic fatigue syndrome, irritable bowel
syndrome, and functional disorders within medicine (e.g.,
noncardiac chest pain, functional dysphagia) as well as certain
medical disorders (e.g., gastroesophageal reﬂux, asthma).
Alternatively, one can use a dimensional psychopathology
approach to link processes underlying interoceptive dysfunc-
tion to psychiatric disorders. Transdiagnostic perspectives
such as those provided by the Research Domain Criteria (109)
may be particularly helpful in identifying the potential role
played by various interoceptive processes because several of
these might not be readily identiﬁed at the symptom reportce and Neuroimaging - 2018; -:-–- www.sobp.org/BPCNNI 7
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entered into the diagnostic speciﬁcations for DSM. This would
allow for identiﬁcation of mechanistic dysfunctions across
units of analyses and might bridge the biological gap in current
diagnostic classiﬁcation frameworks by directly probing the
links between physiological and psychological dysfunctions.
Interoceptive investigations in mental health populations might
reveal evidence of 1) attentional bias (e.g., hypervigilance), 2)
distorted physiological sensitivity (e.g., blunted or heightened
magnitude estimation in response to a perturbation), 3)
cognitive bias (e.g., catastrophizing in response to an antici-
pated stimulus), 4) abnormal sensibility (e.g., tendency to label
one’s experiences in a particular way), and 5) impaired insight
(e.g., poor conﬁdence–accuracy correspondence on a task).
Determining whether interoceptive processes are a cause or
consequence of developmental psychopathology, and which
factors might affect this development (such as early life stress
or pain), will be an important area for future research. Such
studies may beneﬁt from the examination of younger (110,111)
or older (112,113) samples and premorbid identiﬁcation and
longitudinal tracking of individuals (114). Investigating the role
of social cognition/theory of mind in clinically relevant intero-
ceptive inference generation represents another ripe opportu-
nity (115).Interoceptive Tests and/or Biomarkers
Because interoception is fundamentally a process linking body
and brain, it is conceivable that objective measures of this
process could serve as biological indicators of disease states.
However, there is currently limited evidence for interoceptive
predictors of diagnostic, prognostic, or treatment status
(33,116,117). Biomarkers, such as those derived from neuro-
imaging or blood measurements, should be sensitive, speciﬁc,
and unaffected by cognitive and emotional inﬂuences. How-
ever, it seems conceivable that the most clinically sensitive
interoceptive measures might derive from probes that perturb
physiological functions to engage speciﬁc metacognitive be-
liefs and/or expectations about bodily states. Such measures
could facilitate differential diagnosis testing by revealing the
presence of interoceptive dysfunction of biological (within a
physiological system or systems), psychological (e.g., overly
precise expectations about bodily states), or metacognitive
(e.g., discrepant self-efﬁcacy beliefs with regard to homeo-
static/allostatic regulation) origin (37). This approach could be
seen as analogous to a cardiac stress test, such that adequate
engagement of the system under ecologically valid conditions
is required in order to measure its dysfunction.
The most common application of interoceptive evaluation in
current clinical practice occurs during interoceptive exposure
psychotherapy for panic disorder (118). During this procedure,
patients self-induce varieties of interoceptive symptoms via
low-arousal manipulations (e.g., hyperventilation, performing
jumping jacks, spinning in a chair, breathing through a straw)
while the clinician monitors their subjective distress level.
Unfortunately these manipulations often fail to adequately
reproduce the fear response, possibly because the patient
retains full control over the stimulation (the patient can quit at
any time) and the perturbation remains predictable with mini-
mal uncertainty, raising the question of whether modulating8 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging - 2both physiological homeostasis and the perception of
controllability might further improve the ecological validity and
efﬁcacy of interoceptive exposures (119). A test to verify suc-
cessful interoceptive exposure therapy for panic disorder in-
volves completion of a standardized behavioral avoidance
paradigm (120). In this setting, the degree of tolerance to being
enclosed in a small dark chamber for 10 minutes might provide
behavioral evidence verifying tolerance to triggers of intero-
ceptive dysregulation. There is also experimental evidence that
pharmacological interoceptive exposure therapy can reduce
anxiety disorder symptom severity either as monotherapy
(7,121–123) or as an augmentative approach (124). However,
there are few studies of these procedures to date, the impact
of such interventions on longer term outcomes (e.g., 6 months
or beyond) are unknown, and none of these approaches has
translated into clinical practice.
Current Treatments Relevant to Interoception
Among the currently available therapies with an interoceptive
basis are pharmacotherapies directly modulating interoceptive
physiology. Examples include adrenergic blockade (e.g., pro-
pranolol) or agonism (e.g., yohimbine), stimulants (e.g., methyl-
phenidate), benzodiazepines, muscle relaxants, and opioids. A
second example is cognitive behavioral therapy with exposure
and response prevention to reverse or attenuate conditioned
fears or form new learned associations. It is helpful in ameliorating
cognitive biases in numerous disorders, including depression,
obsessive-compulsive disorder, posttraumatic stress disorder
(speciﬁcally prolonged exposure therapy), irritable bowel syn-
drome, and chronic pain. Interoceptive exposure is a special
example demonstrated to be effective in speciﬁc disorders
(especially panic disorder). Behavioral activation therapy for
depression sometimes includes exposure to experiences with
positive interoceptive value. A third example is capnometry-
assisted respiratory training. Based on the assumption that
sustained hypocapnia resulting from hyperventilation is a key
mechanism in the production and maintenance of panic, carbon
dioxide capnography-assisted therapy aims to help patients
voluntarily increase end-tidal partial pressure of carbon dioxide
and tolerate physiological variability associated with panic at-
tacks (125,126). As a fourth example, mindfulness-based stress
reduction, yoga, and other meditation/movement-based treat-
ments may be aimed at improving metacognitive awareness of
mind–body connections by systematically attending to sensa-
tions of breathing, cognitions, and/or other modulated body
states (e.g., muscle stretching) (127).
Interoceptive Treatments on the Horizon
Several emerging technologies may have relevance for inter-
oception and mental health, including Floatation-REST
(reduced environmental stimulation therapy) and perturbation
approaches.
Floatation-REST. This intervention, which systematically
attenuates exteroceptive sensory input to the nervous system,
also appears to noninvasively enhance exposure to intero-
ceptive sensations such as the breath and heartbeat (128).
Preliminary data suggest that a single 1-hour session has a
short-term anxiolytic and antidepressant effect in patients with018; -:-–- www.sobp.org/BPCNNI
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needed to evaluate the safety, feasibility, and potential for
long-term efﬁcacy in psychiatric populations.
Perturbation Approaches. Minimally invasive tools
capable of systematically modulating interoceptive process-
ing, such as inspiratory breathing loads (130), core body
thermomodulation (131,132), and transcutaneous vagus nerve
stimulation (133), are several approaches awaiting further
investigation. Given the hypothesis of noisy baseline afferent
signaling, these approaches may systematically enhance the
signal-to-noise ratio and facilitate interoceptive learning. A key
aspect in discerning clinical efﬁcacy of any perturbation may
be the extent to which the patient perceives controllability over
the intervention and is willing/able to surrender this parameter
in treatment. Interventions in which escape or active avoidance
behaviors are directly measurable may provide especially
meaningful information (134).
ROADMAP
The Road Ahead
Beyond the issues outlined previously, progress in determining
the relevance of interoception for mental health relies on
emphasizing the features that distinguish it from other sensory
modalities. Interoception seemingly involves a high degree of
connectivity within the brain (135). It appears to be tightly
linked to the self and survival through homeostatic mainte-
nance of the body, and by helping us to represent how things
are going in the present with respect to the experienced past
and the anticipated future. These computations may depend
on what has occurred to shape the body’s internal landscape,
and it is in this regard that learning, and malleability of repre-
sentations over time, could play important roles.
The conceptual framework for investigating interoception
may overlap with other processes, including emotion (136)
and pain (137), because each is integral for maintaining
bodily homeostasis. An important endeavor may involve the
identiﬁcation of which neural systems for interoception,
emotion, cognition, and pain are overlapping, interdigitating,
or even possibly identical. Additional effort is needed to
deﬁne the neurophysiological nomenclature, core criteria,
common features, developmental aspects, modulating fac-
tors, functional consequences, and putative pathophysio-
logic mechanisms of interoception in mental health
disorders.
The current work offers some conceptual distinctions and
some mutually agreed-on terminology, with many others still
needed. Several low-hanging fruits, as well as promising
emerging technologies and tools, have been mentioned.
Further empirical work will be critical to delineate how inter-
oception can be mapped to mental health measures, models,
and approaches, and benchmarks for success/failure need to
be established. Models of interoceptive processing that
improve on the traditional stimulus, sensorimotor processing,
and response function concepts have been described, but
these models remain theoretical and await further testing.
Therefore, the current document is best viewed as a work in
progress.Biological Psychiatry: Cognitive NeuroscienACKNOWLEDGMENTS AND DISCLOSURES
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